|
1
|
Wei KR, Xu Y, Liu J, Zhang WJ and Liang
ZH: Histopathological classification of nasopharyngeal carcinoma.
Asian Pac J Cancer Prev. 12:1141–1147. 2011.PubMed/NCBI
|
|
2
|
Zhen Y, Ye Y, Yu X, Mai C, Zhou Y, Chen Y,
Yang H, Lyu X, Song Y, Wu Q, Fu Q, Zhao M, Hua S, Wang H, Liu Z,
Zhang Y and Fang W: Reduced CTGF expression promotes cell growth,
migration, and invasion in nasopharyngeal carcinoma. PLoS One.
8:e649762013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho FC, Tham IW, Earnest A, Lee KM and Lu
JJ: Patterns of regional lymph node metastasis of nasopharyngeal
carcinoma: a meta-analysis of clinical evidence. BMC Cancer.
12:982012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia WH and Qin HD: Non-viral environmental
risk factors for nasopharyngeal carcinoma: a systematic review.
Semin Cancer Biol. 22:117–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brott BK, Pinsky BA and Erikson RL: NLK is
a murine protein kinase related to Erk/MAP kinases and localized in
the nucleus. Proc Natl Acad Sci USA. 95:963–968. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ,
Xie HJ, Ahn YM, Park WS, Lee JY and Nam SW: Targeted disruption of
Nemo-like kinase inhibits tumor cell growth by simultaneous
suppression of cyclin D1 and CDK2 in human hepatocellular
carcinoma. J Cell Biochem. 110:687–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan Z, Li M, Wu W, Zhang L, Ding Q, Wu X,
Mu J and Liu Y: NLK is a key regulator of proliferation and
migration in gallbladder carcinoma cells. Mol Cell Biochem.
369:27–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Zhang S, Wang Z, Zhang B, Wu X, Weng
H, Ding Q, Tan Z, Zhang N, Mu J, Yang J, Shu Y, Bao R, Ding Q, Wu
W, Cao Y and Liu Y: Prognostic significance of nemo-like kinase
(NLK) expression in patients with gallbladder cancer. Tumour Biol.
Jul 16–2013.(Epub ahead of print).
|
|
9
|
Morikawa T, Kuchiba A, Qian ZR,
Mino-Kenudson M, Hornick JL, Yamauchi M, Imamura Y, Liao X,
Nishihara R, Meyerhardt JA, Fuchs CS and Ogino S: Prognostic
significance and molecular associations of tumor growth pattern in
colorectal cancer. Ann Surg Oncol. 19:1944–1953. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morikawa T, Kuchiba A, Yamauchi M,
Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS
and Ogino S: Association of CTNNB1 (beta-catenin) alterations, body
mass index, and physical activity with survival in patients with
colorectal cancer. JAMA. 305:1685–1694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yasuda J, Tsuchiya A, Yamada T, Sakamoto
M, Sekiya T and Hirohashi S: Nemo-like kinase induces apoptosis in
DLD-1 human colon cancer cells. Biochem Biophys Res Commun.
308:227–233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Emami KH, Brown LG, Pitts TE, Sun X,
Vessella RL and Corey E: Nemo-like kinase induces apoptosis and
inhibits androgen receptor signaling in prostate cancer cells.
Prostate. 69:1481–1492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cui G, Li Z, Shao B, Zhao L, Zhou Y, Lu T,
Wang J, Shi X, Wang J, Zuo G, Zhu W and Shen A: Clinical and
biological significance of nemo-like kinase expression in glioma. J
Clin Neurosci. 18:271–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
